Product NDC: | 57664-540 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | Cetirizine Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Cetirizine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-540 |
Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA077499 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071227 |
Package NDC: | 57664-540-88 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (57664-540-88) |
NDC Code | 57664-540-88 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (57664-540-88) |
Product NDC | 57664-540 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Cetirizine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20071227 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes |